-
What You Need to Know About the Covid Vaccines: From Johnson & Johnson's Newly Approved Single-Dose to the Effectiveness of Each One
Here’s how the current Covid vaccine contenders differ, including how long it takes to develop immunity after the shots.
-
$100 Billion Market Cap Is the Blue-Sky Scenario for Moderna, Analyst Says
Moderna, a forerunner in the development of coronavirus vaccines, has the potential to reach a $100 billion-plus market capitalization, according to an analyst.
-
Dr. Scott Gottlieb Says an Estimate for ‘Herd Immunity by April' Too Aggressive But Directionally Right
Former FDA Commissioner Dr. Scott Gottlieb told CNBC on Monday he expects Covid cases in the U.S. to keep declining into the summer.
-
Op-Ed: Trust in Covid Vaccine Needs to Be Earned for Blacks and Latinos After Decades of Mistreatment
After decades of racist disinvestment and medical mistreatment, Black and Latino communities have every reason to be skeptical of the Covid vaccine.
-
Yes, You Can Take OTC Pain Meds After Getting the Covid Vaccine, Says CDC — Plus Other Tips for Dealing With Side Effects
What you can do, and what you shouldn’t do, when it comes to OTC medications and the Covid-19 vaccine.
-
Stocks Inch Higher Friday, Closing Out a Positive Week
Major averages gained on the week but the strong rally to begin February seemed to take a breather.
-
Dr. Kavita Patel: Here's What You Can and Can't Do After Being Fully Vaccinated for Covid
Some Covid precautions remain necessary even after getting both Covid vaccine shots, former Obama administration policy aide Dr. Kavita Patel told CNBC.
-
CDC to Investigate Death of Nebraska Man Who Received Covid Vaccine Dose
The CDC and FDA received 1,170 reports of death among individuals in the U.S. who received a Covid vaccine — 0.003% of vaccinated people — between Dec. 14, 2020, and Feb. 7, 2021.
-
Fauci's Approach to the Two-Dose Vaccine Is the Right One, Says Former CDC Acting Director Richard Besser
Richard Besser, who served as the acting director of the CDC under President Obama, agrees with Dr. Fauci on prioritizing two-dose vaccines.
-
Dr. Scott Gottlieb Expects Covid Vaccine Appointments to Be Widely Available by April in the U.S.
Former FDA chief Dr. Scott Gottlieb told CNBC a lack of demand for Covid vaccines will mean eligibility has to be expanded to more Americans.
-
A 29-Year-Old Nurse Shares Her Experience Getting the Covid-19 Vaccine: ‘A Gleam of Light at the End of the Tunnel'
“After months of uncertainty, fear and ever-changing information, I recall my co-workers and I breathe a collective sigh of relief when vaccine announcements were made,” says Diana DiMarcantonio Kott, a nurse educator. She shares what it was like to get both the first and second dose of the Covid-19 vaccine.
-
Dr. Gottlieb Says J&J Covid Vaccine Trial Yields Very Good Result and Vaccine Will Aid U.S. Pandemic Response
Former FDA chief Dr. Scott Gottlieb said Johnson & Johnson’s single-dose Covid vaccine will be a “great addition” to the U.S. pandemic response.
-
Moderna Asks FDA to Authorize 5 Additional Doses Per COVID Vaccine Vial to Speed Distribution, Source Tells CNBC
Moderna asked the FDA to allow it to put more doses of its COVID-19 vaccine in each vial to alleviate a bottleneck in manufacturing.
-
Operation Warp Speed Chief Resigns at Biden Team's Request, Will Stay Through Transition, Sources Say
The scientific leader of the U.S. vaccine effort will stay in the role for 30 days, but won’t be chief advisor as of Inauguration Day, sources say.
-
1 in 30 Londoners Has Covid as City Mayor Declares a Major Incident
London Mayor Sadiq Khan on Friday declared a major incident over the rapid spread of the coronavirus in the U.K.’s capital city.
-
Pfizer-BioNTech Vaccine Appears to Neutralize a Key Mutation of Covid Variants Found in UK, South Africa
The research, which has not yet been peer-reviewed, suggested the Pfizer-BioNTech vaccine worked to neutralize the so-called N501Y mutation.
-
Dr. Gottlieb Sees 30% of People in U.S. Getting Covid and 10% Vaccinated as of End of January
“You’re starting to get to levels of prior exposure in the population where the virus isn’t going to spread as readily,” Dr. Scott Gottlieb told CNBC.
-
Stocks Begin 2021 With a Sell-Off, Dow Drops More Than 300 Points
Stocks dropped on Monday, the first trading day of 2021, amid concerns about global coronavirus cases and the Georgia runoff elections.
-
Dr. Scott Gottlieb: COVID Vaccine Eligibility Should Be Expanded Now to Deliver More Shots
“You need to stockpile something,” the former FDA chief told CNBC on Monday. “But putting away 50% of all the doses, I think, is denying more people access.”
-
U.S. Could Ramp Up Slow Covid Vaccine Rollout by Giving Two Half Volume Doses of Moderna Shot, Slaoui Says
Moncef Slaoui told CBS that Operation Warp Speed is looking at giving half doses of the Moderna vaccine to certain groups to speed up the Covid vaccine rollout.